Genetic Testing - G2 Intelligence

Staying on Top of Medical Necessity and Marketer Compliance

Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.

Start a Free Trial for immediate access to this article

Already a member? Log in here

First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?

Start a Free Trial for immediate access to this article

Already a member? Log in here